berberine has been researched along with Disbacteriosis in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 8.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Berberine (BBR) is a non-prescription drug to treat various bacteria-associated diarrheas." | 7.91 | Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis. ( Guan, HS; Liu, J; Wang, AT; Wang, CY; Wang, WX; Yan, D; Yang, XY; Yue, SJ, 2019) |
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 4.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Berberine (BBR) is a non-prescription drug to treat various bacteria-associated diarrheas." | 3.91 | Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis. ( Guan, HS; Liu, J; Wang, AT; Wang, CY; Wang, WX; Yan, D; Yang, XY; Yue, SJ, 2019) |
| " However, AA-containing herbs are highly safe in combination with berberine (Ber)-containing herbs in traditional medicine, suggesting the possible neutralizing effect of Ber on the toxicity of AA." | 1.62 | Berberine-Based Heterogeneous Linear Supramolecules Neutralized the Acute Nephrotoxicity of Aristolochic Acid by the Self-Assembly Strategy. ( Feng, Y; Guo, W; Huang, G; Huang, X; Lei, H; Li, T; Li, Y; Tian, X; Wang, P; Xu, A; Yuan, K; Zhao, L; Zhen, J, 2021) |
| "When treated with berberine, the DSS-induced enteric dysbacteriosis could be mitigated and their fecal bacteria were able to reduce acute hepatotoxicity in recipient mice." | 1.48 | Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis. ( Fu, G; Huang, W; Qin, C; Wang, H; Yan, H; Zeng, M; Zhang, H; Zhao, L; Zhou, W, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Z | 1 |
| Cen, C | 1 |
| Ou, Q | 1 |
| Pan, Y | 1 |
| Zhang, J | 2 |
| Huo, D | 1 |
| Chen, K | 1 |
| Li, X | 2 |
| Xu, S | 1 |
| Zhang, Y | 2 |
| Li, K | 1 |
| Gao, XJ | 1 |
| Guo, MY | 1 |
| Cazzaniga, M | 1 |
| Zonzini, GB | 1 |
| Di Pierro, F | 1 |
| Moricoli, S | 1 |
| Bertuccioli, A | 1 |
| Su, C | 1 |
| Jiang, Z | 1 |
| Yang, Y | 1 |
| Yang, M | 1 |
| Zhang, X | 1 |
| Du, Y | 1 |
| Wang, L | 1 |
| Jiang, J | 1 |
| Hong, B | 1 |
| Wang, P | 1 |
| Guo, W | 1 |
| Huang, G | 1 |
| Zhen, J | 1 |
| Li, Y | 1 |
| Li, T | 1 |
| Zhao, L | 2 |
| Yuan, K | 1 |
| Tian, X | 1 |
| Huang, X | 1 |
| Feng, Y | 1 |
| Lei, H | 1 |
| Xu, A | 1 |
| Brown, BI | 1 |
| Qin, C | 1 |
| Zhang, H | 1 |
| Zeng, M | 1 |
| Huang, W | 1 |
| Fu, G | 1 |
| Zhou, W | 1 |
| Wang, H | 1 |
| Yan, H | 1 |
| Yue, SJ | 2 |
| Liu, J | 2 |
| Wang, AT | 2 |
| Meng, XT | 1 |
| Yang, ZR | 1 |
| Peng, C | 1 |
| Guan, HS | 2 |
| Wang, CY | 2 |
| Yan, D | 2 |
| Wang, WX | 1 |
| Yang, XY | 1 |
1 review available for berberine and Disbacteriosis
| Article | Year |
|---|---|
Nutritional Management of Metabolic Endotoxemia: A Clinical Review.
Topics: Anti-Infective Agents; Berberine; Diet Therapy; Dysbiosis; Endotoxemia; Fermentation; Glutamine; Hum | 2017 |
8 other studies available for berberine and Disbacteriosis
| Article | Year |
|---|---|
The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome.
Topics: Berberine; Biomarkers; Disease Management; Drug Therapy, Combination; Dysbiosis; Gastrointestinal Mi | 2021 |
Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
Topics: Animals; Berberine; Cats; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Anim | 2022 |
Gut Microbiota, Metabolic Disorders and Breast Cancer: Could Berberine Turn Out to Be a Transversal Nutraceutical Tool? A Narrative Analysis.
Topics: Berberine; Breast Neoplasms; Butyrates; Dysbiosis; Estrogens; Fatty Acids, Volatile; Female; Gastroi | 2022 |
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Topics: Animals; Atherosclerosis; Berberine; Choline; Diet; Disease Models, Animal; Disease Susceptibility; | 2021 |
Berberine-Based Heterogeneous Linear Supramolecules Neutralized the Acute Nephrotoxicity of Aristolochic Acid by the Self-Assembly Strategy.
Topics: Animals; Aristolochic Acids; Berberine; Drug Interactions; Drugs, Chinese Herbal; Dysbiosis; Gastroi | 2021 |
Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis.
Topics: Animals; Berberine; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dysbiosis; Fecal | 2018 |
Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; | 2019 |
Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis.
Topics: Animals; Berberine; Biodiversity; Cecum; Colon; Diarrhea; Dysbiosis; Fatty Acids; Feces; Gastrointes | 2019 |